DESTINA Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $250K

  • Investors
  • 5

DESTINA General Information

Description

Developer of molecular diagnostic products designed to detect nucleic acids and single nucleotide polymorphisms (SNPs). The company's product and services are based on a molecular diagnostic that focuses on the development of simpler, accurate, and cost-effective products for PCR-free detection of microRNAs, enabling healthcare providers to treat toxicology, illness, and diseases of patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenida de la Innovación, 1
  • Los Vergeles
  • 18100 Granada
  • Spain
+34 958
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Avenida de la Innovación, 1
  • Los Vergeles
  • 18100 Granada
  • Spain
+34 958

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DESTINA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 22-May-2017 $250K Completed Product In Beta Test
8. Later Stage VC 02-Oct-2014 Completed Product In Beta Test
7. Grant 01-Nov-2012 Completed Startup
6. Early Stage VC 01-Sep-2012 Completed Startup
5. Seed Round 04-Mar-2011 Completed Startup
4. Grant 01-Jan-2011 Completed Startup
3. Seed Round 17-Dec-2010 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Seed Round 01-Jan-2008 Completed Startup
To view DESTINA’s complete valuation and funding history, request access »

DESTINA Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 2
Ordinary 1
To view DESTINA’s complete cap table history, request access »

DESTINA Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular diagnostic products designed to detect nucleic acids and single nucleotide polymorphisms (SNPs).
Biotechnology
Granada, Spain
4 As of 2023

Cambridge, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DESTINA Competitors (18)

One of DESTINA’s 18 competitors is Voyager Therapeutics, a Corporation company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Corporation Cambridge, MA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Wayfinder Biosciences Venture Capital-Backed Seattle, WA
Tiba Biotech Venture Capital-Backed Cambridge, MA
Gradalis Private Equity-Backed Carrollton, TX
You’re viewing 5 of 18 competitors. Get the full list »

DESTINA Patents

DESTINA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200123592-A1 Single molecule detection and quantification of nucleic acids with single base specificity Inactive 30-May-2017
GB-201616556-D0 Improved pna probe Inactive 12-Jul-2016
US-11242526-B2 Pna probe Active 12-Jul-2016
US-20190233818-A1 Improved pna probe Active 12-Jul-2016
EP-3485014-A1 Pna probe Active 12-Jul-2016 C12Q1/6876
To view DESTINA’s complete patent history, request access »

DESTINA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DESTINA Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Old College Capital Corporate Venture Capital Minority
Vitro PE-Backed Company Minority
University of Edinburgh Endowment Limited Partner Minority
Scottish Enterprise Government Minority
SantanderX Accelerator/Incubator
To view DESTINA’s complete investors history, request access »

DESTINA FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »